Cetera Investment Advisers’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-1,601
Closed -$233K 539
2019
Q1
$233K Buy
+1,601
New +$232K 0.03% 421
2018
Q4
Sell
-1,237
Closed -$235K 514
2018
Q3
$235K Buy
+1,237
New +$227K 0.03% 425
2017
Q4
Sell
-3,096
Closed -$632K 423
2017
Q3
$632K Sell
3,096
-716
-19% -$167K 0.14% 193
2017
Q2
$924K Sell
3,812
-350
-8% -$82.2K 0.23% 123
2017
Q1
$994K Sell
4,162
-2,296
-36% -$535K 0.27% 105
2016
Q4
$1.36M Buy
+6,458
New +$1.34M 0.45% 61

Other funds holding AGN

Cetera Investment Advisers's AGN Position: Q2 2019 in Review

Cetera Investment Advisers sold out of Allergan plc (AGN) in Q2 2019, closing a stake of 1,601 shares — an estimated $233K sold.

Cetera Investment Advisers first reported a position in AGN in Q4 2016 and held it in 6 quarters. The position peaked at $1.36M in Q4 2016. 971 funds tracked by Wall St. Rank hold AGN as of Q2 2019.

  • Cetera Investment Advisers reported no remaining Allergan plc position as of Q2 2019 after selling out during the quarter.
  • Cetera Investment Advisers sold 1,601 Allergan plc shares in Q2 2019, an estimated $233K.
  • Cetera Investment Advisers first reported a position in Allergan plc in Q4 2016 and held it in 6 quarters.
  • Cetera Investment Advisers's Allergan plc position peaked at $1.36M in Q4 2016.
  • 971 funds tracked by Wall St. Rank held Allergan plc as of Q2 2019.

Based on Cetera Investment Advisers's 13F filing for Q2 2019, filed 12 Aug 2019.